[RESULTS OF THE TREATMENT OF MALIGNANT BLOOD DISEASES WITH RUFOCROMOMYCIN (RP 5278). APROPOS OF 57 CASES].
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D001798:Blood Proteins; D004358:Drug Therapy; D006402:Hematologic Diseases; D006689:Hodgkin Disease; D006801:Humans; D007938:Leukemia; D008223:Lymphoma; D016403:Lymphoma, Large B-Cell, Diffuse; D008228:Lymphoma, Non-Hodgkin; D008545:Melanoma; D009369:Neoplasms; D011859:Radiography; D012509:Sarcoma; D013308:Streptonigrin
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D001798:Blood Proteins; D013308:Streptonigrin
ANTIBIOTICS; ANTINEOPLASTIC AGENTS; BLOOD PROTEINS; DRUG THERAPY; HODGKIN'S DISEASE; LEUKEMIA; LYMPHOSARCOMA; MELANOMA; RADIOGRAPHY; SARCOMA; SARCOMA, RETICULUM CELL
R'ESULTATS DU TRAITEMENT DES H'EMOPATHIES MALIGNES PAR LA RUFOCROMOMYCINE (5278 RP). A PROPOS DE 57 OBSERVATIONS.